Research

Energy balance

No significant differences in adverse events were observed between semaglutide and comparator groups.

This suggests that semaglutide is as safe as other treatments in terms of adverse events.

StrongSupportsmedium confidence
No significant differences were observed between semaglutide and comparator groups.
Frederick Berro Rivera et al. · Current Medical Research and Opinion · 2024

Why this rating

Based on the meta-analysis of 23 studies with a large sample size.

Source

Evaluating the safety profile of semaglutide: an updated meta-analysis

Frederick Berro Rivera et al. · Current Medical Research and Opinion · 2024

DOI 10.1080/03007995.2024.2383731

Meta-analysisCited 10×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →